Sign Up to like & get
recommendations!
1
Published in 2018 at "Cancer"
DOI: 10.1002/cncr.31646
Abstract: Emerging biologic subsets and new prognostic markers are significantly and adversely affecting curability after standard chemoimmunotherapy for aggressive B‐cell lymphomas. The identification of concurrent MYC and B‐cell CLL/lymphoma 2 (BCL2) deregulation, whether at a genomic…
read more here.
Keywords:
lymphoma;
double hit;
cell lymphomas;
hit double ... See more keywords